Ningbo Heqin Chemistry Co.,Ltd. – Trademark Portfolio

Entity Type: 16

Ningbo Heqin Chemistry Co.,Ltd. holds 2 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 25 (Clothing) — 1 filings in this category. The portfolio also extends into Class 18 (Leather Goods) across 2 Nice Classification classes. Currently, 1 trademark is registered. Notable registered marks include CITYORK. The owner is based in Ningbo.

NO.492 Fuming Road, Yinzhou Dist.

Ningbo 315000 , CN

2 Total Trademarks

Add to watchlist:

No watchlists yet
Loading...
By Date
By Name
Filter by Class:

CITYORK
CITYORK
Registered 2018
CITYORK
CITYORK
Cancelled 2018

Trademark Classifications

Ningbo Heqin Chemistry Co.,Ltd.'s trademark portfolio spans 2 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.

25
Clothing (1 filing)

Clothing, footwear, headgear

18
Leather Goods (1 filing)

Leather and imitations of leather; animal skins, hides; trunks and travelling bags

Frequently Asked Questions

How many trademarks does Ningbo Heqin Chemistry Co.,Ltd. have?

Ningbo Heqin Chemistry Co.,Ltd. has 2 U.S. trademarks filed with the USPTO. Of these, 1 registered, 1 cancelled.

What trademark classes does Ningbo Heqin Chemistry Co.,Ltd. file in?

Ningbo Heqin Chemistry Co.,Ltd. files trademarks across 2 Nice Classification classes. The most active classes are Class 25 (Clothing), Class 18 (Leather Goods). Class 25 covers clothing, footwear, headgear.

What are Ningbo Heqin Chemistry Co.,Ltd.'s most well-known trademarks?

Ningbo Heqin Chemistry Co.,Ltd.'s registered trademark portfolio includes well-known marks such as CITYORK. These are among 1 currently registered trademark in the portfolio.

What is Ningbo Heqin Chemistry Co.,Ltd.'s trademark registration success rate?

Ningbo Heqin Chemistry Co.,Ltd. has a 50% trademark registration rate, with 1 out of 2 resolved applications resulting in successful registration. Currently, 0 applications are pending review.